Corient Private Wealth LP Acquires 49,898 Shares of Docusign Inc. $DOCU

Key Points

• Corient Private Wealth increased its Docusign holdings by 21%, purchasing 49,898 shares to own 287,386 shares worth approximately $12.8 million. Institutional investors collectively own 77.64% of DOCU.
• Docusign reported stronger-than-expected quarterly results, with EPS of $1.16 versus $1.09 expected and revenue of $875.75 million, up 9.4% year over year.
• Insiders sold 182,698 shares worth $10.5 million over the past 90 days, while analysts maintain a broadly cautious stance: DOCU has an average “Hold” rating and a consensus price target of $67.33.

Corient Private Wealth LP increased its holdings in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 21.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 287,386 shares of the company's stock after buying an additional 49,898 shares during the period. Corient Private Wealth LP owned about 0.15% of Docusign worth $12,766,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in DOCU. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in shares of Docusign during the second quarter worth $3,247,000. Ameritas Advisory Services LLC raised its position in Docusign by 225.5% during the 2nd quarter. Ameritas Advisory Services LLC now owns 25,109 shares of the company's stock worth $1,115,000 after purchasing an additional 17,395 shares during the last quarter. HB Wealth Management LLC lifted its holdings in Docusign by 30.0% during the 2nd quarter. HB Wealth Management LLC now owns 11,632 shares of the company's stock worth $517,000 after buying an additional 2,687 shares during the period. Compass Financial Management LLC acquired a new position in Docusign during the 2nd quarter worth about $61,000. Finally, AlphaGrep UK Ltd bought a new stake in shares of Docusign in the 2nd quarter valued at about $323,000. 77.64% of the stock is owned by institutional investors.

Insider Transactions at Docusign

In other news, insider James P. Shaughnessy sold 12,000 shares of the firm's stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $45.54, for a total transaction of $546,480.00. Following the completion of the sale, the insider owned 52,815 shares of the company's stock, valued at $2,405,195.10. This trade represents a 18.51% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Peter Solvik sold 46,000 shares of Docusign stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $65.24, for a total transaction of $3,001,040.00. Following the completion of the sale, the director owned 49,558 shares of the company's stock, valued at $3,233,163.92. This represents a 48.14% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 182,698 shares of company stock valued at $10,480,456. 0.59% of the stock is owned by insiders.

Docusign Trading Up 3.0%

Shares of Docusign stock opened at $71.85 on Wednesday. The business has a 50-day moving average price of $58.70 and a two-hundred day moving average price of $51.06. Docusign Inc. has a 1-year low of $40.16 and a 1-year high of $86.65. The company has a market cap of $13.43 billion, a P/E ratio of 43.81, a PEG ratio of 2.63 and a beta of 0.90.

Docusign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings data on Thursday, September 3rd. The company reported $1.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.09 by $0.07. Docusign had a return on equity of 18.29% and a net margin of 9.82%.The company had revenue of $875.75 million for the quarter, compared to the consensus estimate of $867.22 million. During the same period in the previous year, the business earned $0.30 EPS. The firm's revenue was up 9.4% compared to the same quarter last year. Equities research analysts forecast that Docusign Inc. will post 2.1 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on DOCU shares. Morgan Stanley increased their price target on Docusign from $69.00 to $75.00 and gave the company an "equal weight" rating in a research note on Friday, September 4th. Citizens Jmp reaffirmed a "market outperform" rating and issued a $86.00 price objective on shares of Docusign in a research note on Friday, September 4th. Weiss Ratings upgraded Docusign from a "hold (c-)" rating to a "hold (c)" rating in a report on Tuesday, August 25th. Wall Street Zen downgraded shares of Docusign from a "strong-buy" rating to a "buy" rating in a research report on Sunday, August 2nd. Finally, Jefferies Financial Group raised their price target on shares of Docusign from $45.00 to $50.00 and gave the stock a "hold" rating in a report on Friday, June 5th. Three equities research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Docusign has an average rating of "Hold" and an average target price of $67.33.

More Docusign News

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Docusign was named a Leader in the 2026 IDC MarketScape for Worldwide Integrated Signing Workflow Software. The recognition supports the company’s competitive position as it expands Intelligent Agreement Management (IAM) and AI-powered workflow products. Docusign Named a Leader in the IDC MarketScape
• Positive Sentiment: Investors continue to focus on Docusign’s AI initiatives, including IAM integrations and the opening of its Model Context Protocol Server to AI agents. The company also raised full-year revenue guidance and completed a $2.38 billion share-repurchase program covering slightly more than 20% of its shares, potentially supporting earnings per share and shareholder returns. Docusign’s AI Push and Buyback
• Positive Sentiment: Analysts raised the consensus price target by 17.43% to $71.83, indicating improved expectations for DOCU’s valuation and outlook. DocuSign Consensus Price Target Raised
• Positive Sentiment: Recent results showed revenue of $875.75 million, net income of $77.72 million and stronger-than-expected earnings, while revenue increased 9.4% year over year. These results, along with buybacks and AI adoption, have reinforced the bullish long-term case. Reasons to Hold Docusign Stock
• Neutral Sentiment: Director Anna Marrs sold 548 shares for approximately $36,716 under a pre-arranged Rule 10b5-1 plan. Because the sale was planned and represented only 3.89% of her holdings, it is less likely to signal a change in management’s outlook. SEC Insider Trading Filing

Docusign Profile

DocuSign, Inc is a provider of digital agreement management and electronic signature solutions. Its platform enables individuals and organizations to prepare, send, sign, manage and store agreements electronically, helping businesses replace paper-based contracting processes with digital workflows.

The company's products and services include DocuSign eSignature, which supports electronic signing and authentication, as well as tools for contract lifecycle management, agreement preparation, identity verification, notarial services and workflow automation.

Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCU - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.